Molecular Mechanisms and Cellular Contribution from Lung Fibrosis to Lung Cancer Development
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrosing interstitial lung disease (ILD) of unknown aetiology, with a median survival of 2–4 years from the time of diagnosis. Although IPF has unknown aetiology by definition, there have been identified several risks factors increasing...
Main Authors: | Anna Valeria Samarelli, Valentina Masciale, Beatrice Aramini, Georgina Pamela Coló, Roberto Tonelli, Alessandro Marchioni, Giulia Bruzzi, Filippo Gozzi, Dario Andrisani, Ivana Castaniere, Linda Manicardi, Antonio Moretti, Luca Tabbì, Giorgia Guaitoli, Stefania Cerri, Massimo Dominici, Enrico Clini |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-11-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/22/12179 |
Similar Items
-
Fibrotic Idiopathic Interstitial Lung Disease: The Molecular and Cellular Key Players
by: Anna Valeria Samarelli, et al.
Published: (2021-08-01) -
Proteomic profiling of formalin-fixed paraffine-embedded tissue reveals key proteins related to lung dysfunction in idiopathic pulmonary fibrosis
by: Anna Valeria Samarelli, et al.
Published: (2024-01-01) -
Biological effects of COVID-19 on lung cancer: Can we drive our decisions
by: Beatrice Aramini, et al.
Published: (2022-10-01) -
Pulmonary Stretch and Lung Mechanotransduction: Implications for Progression in the Fibrotic Lung
by: Alessandro Marchioni, et al.
Published: (2021-06-01) -
A High-Throughput System for Cyclic Stretching of Precision-Cut Lung Slices During Acute Cigarette Smoke Extract Exposure
by: Jarred R. Mondoñedo, et al.
Published: (2020-06-01)